Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: Pooled analysis of three randomized controlled trials

Thrombosis Journal

Volumn 10, Issue , 2012, Pages

  Rosencher, Nadia ^a   Noack, Herbert ^b   Feuring, Martin ^b   Clemens, Andreas ^b   Friedman, Richard J ^c   Eriksson, Bengt I ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding; Dabigatran etexilate; Thromboprophylaxis; Type of anaesthesia; Venous thromboembolism

Indexed keywords

DABIGATRAN ETEXILATE; ENOXAPARIN;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL ANESTHESIA; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NERVE BLOCK; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; VENOUS THROMBOEMBOLISM;

EID: 84864189045     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-10-9     Document Type: Article

References (28)

1. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest 2001, 119:132S-175S. 10.1378/chest.119.1_suppl.132S, 11157647.
2. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S-453S. 10.1378/chest.08-0656, 18574271.
3. Rosencher N. Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations. Anaesthesia 2004, 59:803-810. 10.1111/j.1365-2044.2004.03840.x, 15270973.
4. European Public Assessment Report European Medicines Agency 2012, [http://www.emea.europa.eu/humandocs/Humans/EPAR/pradaxa/pradaxa.htm] Accessed January 23, European Public Assessment Report.
5. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007, 5:2178-2185. 10.1111/j.1538-7836.2007.02748.x, 17764540.
6. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007, 370:949-956. 10.1016/S0140-6736(07)61445-7, 17869635.
7. Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, et al. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty 2009, 24:1-9.
8. Anderson FA, Hirsh J, White K, Fitzgerald RH. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 2003, 124:349S-356S. 10.1378/chest.124.6_suppl.349S, 14668417.
9. Nicholls B. Lower limb nerve blocks. Anaesthesia 2010, 11:105-108.
10. Rosencher N, Bonnet MP, Sessler DI. Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies. Anaesthesia 2007, 62:1154-1160. 10.1111/j.1365-2044.2007.05195.x, 17924897.
11. Macfarlane AJ, Prasad GA, Chan VW, Brull R. Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth 2009, 103:335-345. 10.1093/bja/aep208, 19628483.
12. Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk (effective May 31, 2008) CPMP/EWP/707/98 Rev. 1. European Medicines Agency 2012, [http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003301.pdf] Accessed January 23, Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk (effective May 31, 2008).
13. Eriksson BI, Dahl OE, Buller HR, Hettiarachchi R, Rosencher N, Bravo ML, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005, 3:103-111. 10.1111/j.1538-7836.2004.01100.x, 15634273.
14. Chelly JE, Greger J, Gebhard R, Coupe K, Clyburn TA, Buckle R, et al. Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty. J Arthroplasty 2001, 16:436-445. 10.1054/arth.2001.23622, 11402405.
15. Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. Br J Anaesth 2008, 100:154-164.
16. Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama CM. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 2005, 3:2006-2014. 10.1111/j.1538-7836.2005.01545.x, 16102107.
17. Turpie AG, Eriksson BI, Bauer KA, Lassen MR. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest 2003, 124:371S-378S. 10.1378/chest.124.6_suppl.371S, 14668420.
18. Modig J. The role of lumbar epidural anaesthesia as antithrombotic prophylaxis in total hip replacement. Acta Chir Scand 1985, 151:589-594.
19. Prins MH, Hirsh J. A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical review. Thromb Haemost 1990, 64:497-500.
20. Samama CM, Barre J, Clergue F, Samii K. [Benefits of regional anesthesia. Anticoagulant treatment and regional anesthesia]. Ann Fr Anesth Reanim 1992, 11:282-287. 10.1016/S0750-7658(05)80360-0, 1380214.
21. O'Hara DA, Duff A, Berlin JA, Poses RM, Lawrence VA, Huber EC, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000, 92:947-957. 10.1097/00000542-200004000-00011, 10754613.
22. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, Van ZA, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000, 321:1493. 10.1136/bmj.321.7275.1493, 27550, 11118174.
23. Sorenson RM, Pace NL. Anesthetic techniques during surgical repair of femoral neck fractures. A meta-analysis. Anesthesiology 1992, 77:1095-1104. 10.1097/00000542-199212000-00009, 1466461.
24. Urwin SC, Parker MJ, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000, 84:450-455. 10.1093/oxfordjournals.bja.a013468, 10823094.
25. Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res 2010, 126:175-182. 10.1016/j.thromres.2010.03.021, 20434759.
26. Manoir BD, Bourget P, Langlois M, Szekely B, Fischler M, Chauvin M, et al. Evaluation of the pharmacokinetic profile and analgesic efficacy of oral morphine after total hip arthroplasty. Eur J Anaesthesiol 2006, 23:748-754. 10.1017/S0265021506000731, 16723055.
27. Dahl OE, Kurth AA, Rosencher N, Schnee JM, Clemens A, Hantel S, et al. Delay in initiating prophylactic treatment with dabigatran etxilate following total hip or knee replacement surgery did not affect efficacy. Pooled analysis of two European phase III trials [abstract]. J Thromb Haemost 2009, 7(Suppl):695.
28. Dahl OE, Kurth AA, Rosencher N, Noack H, Clemens A, Eriksson BI. Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing hip or knee replacement. Int Orthop 2011, 36:741-748.